Ticker > Company >

TruAlt Bioenergy share price

TruAlt Bioenergy Ltd.

NSE: TRUALT BSE: 544545 SECTOR: Breweries & Distilleries  5.2 K   5   3

423.05
-22.00 (-4.94%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 449.5

Today's Low

₹ 399.25

52 Week High

₹ 550

52 Week Low

₹ 401.75

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

3627.76 Cr.

Enterprise Value

5012.38 Cr.

No. of Shares

8.58 Cr.

P/E

25.8

P/B

1.71

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  247.86

CASH

147.83 Cr.

DEBT

1532.45 Cr.

Promoter Holding

70.55 %

EPS (TTM)

₹  16.4

Sales Growth

54.48%

ROE

31.61 %

ROCE

13.87%

Profit Growth

306.27 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year54.48%
3 Year∞%
5 YearNA

Profit Growth

1 Year306.27%
3 Year2152.86%
5 YearNA

ROE%

1 Year31.61%
3 Year46.47%

ROCE %

1 Year13.87%
3 Year12.45%

Debt/Equity

1.9966

Price to Cash Flow

10.81

Interest Cover Ratio

2.0788

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2025 70.55 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 46.471% over the past 3 years.
  • Company’s PEG ratio is 0.080263123741342.
  • The company has an efficient Cash Conversion Cycle of 9.31909999999999 days.
  • The company has a high promoter holding of 70.55%.

 Limitations

  • The company has a low EBITDA margin of 0% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2025 Sep 2025
Net Sales 293.94 104.48
Total Expenditure 259.04 116.27
Operating Profit 34.89 -11.79
Other Income 22.56 14.63
Interest 37.25 38.01
Depreciation 20.07 20.3
Exceptional Items 0 0
Profit Before Tax 0.13 -55.48
Tax 0.11 -12.73
Profit After Tax 0.03 -42.75
Adjusted EPS (Rs) 0 -4.98

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 0 762.38 1217.08 1880.12
Total Expenditure 0.01 657.33 1029.33 1582.92
Operating Profit -0.01 105.05 187.75 297.19
Other Income 0 0 56.35 60.59
Interest 0 35.31 141.01 141.04
Depreciation 0 20.75 55.78 64.6
Exceptional Items 0 0 0 0
Profit Before Tax -0.01 48.99 47.3 152.15
Tax 0 13.53 12.69 11.54
Net Profit -0.01 35.46 34.61 140.62
Adjusted EPS (Rs.) -2.02 5.33 4.71 19.84

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 0.06 207.98 207.98 70.63
Total Reserves -0.01 32.52 61.18 696.9
Borrowings 0 1070.33 954.35 1102.86
Other N/C liabilities 0 102.62 105.35 85.95
Current liabilities 0.01 442.53 1034.31 1021.41
Total Liabilities 0.06 1855.98 2363.17 2977.76
Assets
Net Block 0 1301.58 1370.51 1771.77
Capital WIP 0 9.62 201.25 2.78
Intangible WIP 0 0 0 0
Investments 0 0 16.92 16.92
Loans & Advances 0 76.48 131.7 137.48
Other N/C Assets 0 4.2 0.55 1.53
Current Assets 0.06 464.1 642.24 1047.29
Total Assets 0.06 1855.98 2363.17 2977.76
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations -0.01 48.99 47.3 152.15
Adjustment 0 56.31 196.81 193.29
Changes in Assets & Liabilities 0.01 128.19 -211.81 -12.2
Tax Paid 0 0 -3.97 2.26
Operating Cash Flow 0 233.49 28.33 335.5
Investing Cash Flow 0 -1148.58 -388.82 -256.99
Financing Cash Flow 0.06 919.81 373.09 51.94
Net Cash Flow 0.06 4.72 12.6 130.45

Corporate Actions

Investors Details

PARTICULARS Sep 2025%
promoters 70.55
dhraksayani sangamesh nir... 5.10
kamala murigeppa nirani 4.93
murugesh rudrappa nirani 1.24
nirani holdings privateli... 1.43
sangamesh rudrappa nirani... 5.10
sushmitha vijaykumar nira... 17.00
vijaykumar nirani 17.88
vishal nirani 17.87
PARTICULARS Sep 2025%
investors 29.45
chartered finance & leasi... 1.43
rakeshkumar viththalbhai ... 3.82
tata mutual fund - tata a... 1.06

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit and Research reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation and Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

TruAlt Bioenergy Stock Price Analysis and Quick Research Report. Is TruAlt Bioenergy an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse TruAlt Bioenergy. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). TruAlt Bioenergy has a PE ratio of 25.5766017392577 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. TruAlt Bioenergy has ROA of 5.2656% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. TruAlt Bioenergy has a Current ratio of 1.0253.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. TruAlt Bioenergy has a ROE of 31.6063%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. TruAlt Bioenergy has a Debt to Equity ratio of 1.9966 which means that the company has low proportion of debt in its capital.

  • Sales growth: TruAlt Bioenergy has reported revenue growth of 54.4777% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of TruAlt Bioenergy for the current financial year is 15.8072004683114%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for TruAlt Bioenergy is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of TruAlt Bioenergy is Rs 16.3978. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of TruAlt Bioenergy in Ticker for free. Also, one can get the intrinsic value of TruAlt Bioenergy by using Valuation Calculators, which are available with a Finology ONE subscription. 

TruAlt Bioenergy FAQs

Q1. What is TruAlt Bioenergy share price today?
Ans: The current share price of TruAlt Bioenergy is Rs 419.4.

Q2. What is the market capitalisation of TruAlt Bioenergy?
Ans: TruAlt Bioenergy has a market capitalisation of Rs 3596.46366654 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of TruAlt Bioenergy?
Ans: The PE ratio of TruAlt Bioenergy is 25.5766017392577 and the P/B ratio of TruAlt Bioenergy is 1.69207127033239, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of TruAlt Bioenergy share?
Ans: The 52-week high share price of TruAlt Bioenergy is Rs 549, and the 52-week low share price of TruAlt Bioenergy is Rs 401.85.

Q5. Does TruAlt Bioenergy pay dividends?
Ans: Currently, TruAlt Bioenergy does not pay dividends. Dividend yield of TruAlt Bioenergy is around 0%.

Q6. What are the face value and book value of TruAlt Bioenergy shares?
Ans: The face value of TruAlt Bioenergy shares is Rs 10, while the book value per share of TruAlt Bioenergy is around Rs 247.8619. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of TruAlt Bioenergy?
Ans: TruAlt Bioenergy has a total debt of Rs 1532.4472 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of TruAlt Bioenergy?
Ans: The ROE of TruAlt Bioenergy is 31.6063% and ROCE of TruAlt Bioenergy is 13.8742%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is TruAlt Bioenergy a good buy for the long term?
Ans: The TruAlt Bioenergy long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is TruAlt Bioenergy undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the TruAlt Bioenergy appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check TruAlt Bioenergy’s financials?
Ans: You can review TruAlt Bioenergy’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about TruAlt Bioenergy
X